1 Min Read
Dec 21 (Reuters) - Oryzon Genomics SA :
* Receives public funding of 0.74 million euros ($770,192) to develop its epigenetic inhibitors project
Further company coverage: ($1 = 0.9608 euros) (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.